Pricing of Drugs with Evidence Development

Michael K. Gusmano; David Chinitz; Victor Rodwin

doi:10.1001/jama.2022.11232

Pricing of Drugs with Evidence Development

Michael K. Gusmano^*
, David Chinitz
, Victor Rodwin

^*Corresponding author for this work

Braun School of Public Health and Community Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	777-778
Number of pages	2
Journal	JAMA - Journal of the American Medical Association
Volume	328
Issue number	8
DOIs	https://doi.org/10.1001/jama.2022.11232
State	Published - 23 Aug 2022

Access to Document

10.1001/jama.2022.11232

Cite this

@article{249bf2d411bc4f29887bc74a08e46afb,

title = "Pricing of Drugs with Evidence Development",

author = "Gusmano, \{Michael K.\} and David Chinitz and Victor Rodwin",

year = "2022",

month = aug,

day = "23",

doi = "10.1001/jama.2022.11232",

language = "אנגלית",

volume = "328",

pages = "777--778",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "8",

}

TY - JOUR

T1 - Pricing of Drugs with Evidence Development

AU - Gusmano, Michael K.

AU - Chinitz, David

AU - Rodwin, Victor

PY - 2022/8/23

Y1 - 2022/8/23

UR - https://www.scopus.com/pages/publications/85137124267

U2 - 10.1001/jama.2022.11232

DO - 10.1001/jama.2022.11232

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 35997742

AN - SCOPUS:85137124267

SN - 0098-7484

VL - 328

SP - 777

EP - 778

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 8

ER -

Pricing of Drugs with Evidence Development

Access to Document

Other files and links

Cite this